Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | FABP7 | O15540 | 2/20 | 0.48 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.48 |
| ▸ | CASP3 | P42574 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | MDM4 | O15151 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6375583 | 0.88 | KMT2A (0.66) | KMT2AEPHX2FABP7FABP5CASP3 | |
| SCHEMBL30697177 | 0.86 | KMT2A (0.63) | KMT2AEPHX2FABP7FABP5CASP3 | |
| SCHEMBL16140731 | 0.86 | KMT2A (0.63) | KMT2AEPHX2FABP7FABP5CASP3 | |
| SCHEMBL7595024 | 0.85 | KMT2A (0.70) | KMT2AEPHX2FABP7FABP5CASP3 | |
| SCHEMBL1770756 | 0.84 | KMT2A (0.61) | KMT2AEPHX2FABP7FABP5CASP3 | |
| SCHEMBL17773317 | 0.84 | KMT2A (0.68) | KMT2AEPHX2FABP7FABP5CASP3 | |
| SCHEMBL21525041 | 0.84 | KMT2A (0.61) | KMT2AEPHX2FABP7FABP5CASP3 | |
| SCHEMBL30733150 | 0.84 | KMT2A (0.61) | KMT2AEPHX2FABP7FABP5CASP3 | |
| SCHEMBL19893094 | 0.84 | KMT2A (0.73) | KMT2AEPHX2FABP7FABP5CASP3 | |
| SCHEMBL6380797 | 0.84 | KMT2A (0.62) | KMT2AEPHX2FABP7FABP5CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110609078-A | Method for detecting protein phosphorylation and acetylglucosamine saccharification correlation effect | 南京谱利健生物技术有限公司 | 2019-12-24 | — | — | CN | claimed |
| EP-1140895-B1 | THIOPYRAN COMPOUNDS AS INHIBITORS OF MMP | FUJISAWA PHARMACEUTICAL CO (JP) | 2004-03-24 | — | — | EP | claimed |
| WO-2003018019-A2 | NEW USE OF CYCLIC COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-03-06 | — | — | WO | claimed |
| EP-1140895-A2 | THIOPYRAN COMPOUNDS AS INHIBITORS OF MMP | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-10-10 | — | — | EP | claimed |
| WO-2000040576-A2 | THIOPYRAN COMPOUNDS AS INHIBITORS OF MMP | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-07-13 | — | — | WO | claimed |
| WO-2023109942-A1 | COMPOUND-LINKER CONSTRUCTS COMPRISING NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2023-06-22 | — | — | WO | disclosed |
| CN-110609078-B | Method for detecting protein phosphorylation and acetylglucosamine saccharification correlation effect | 南京谱利健生物技术有限公司 | 2022-03-11 | — | — | CN | disclosed |
| WO-2021060496-A1 | METHOD FOR IMPROVING PHOTOCLEAVAGE EFFICIENCY OF PHOTOCLEAVABLE LINKER, PHOTOCLEAVABLE LINKER-BOUND MAGNETIC PARTICLE, AND MEASUREMENT METHOD FOR MEASURING TARGET SUBSTANCE AND KIT FOR USE THEREWITH | 富士レビオ株式会社 | 2021-04-01 | — | — | WO | disclosed |
| CN-110609078-A | Method for detecting protein phosphorylation and acetylglucosamine saccharification correlation effect | 南京谱利健生物技术有限公司 | 2019-12-24 | — | — | CN | disclosed |
| EP-3104893-A1 | FACTOR VIII CONJUGATES | Novo Nordisk A/S (DK) | 2016-12-21 | — | — | EP | disclosed |
| EP-3104894-A1 | FACTOR VII CONJUGATES | Novo Nordisk Health Care AG (CH) | 2016-12-21 | — | — | EP | disclosed |
| EP-3104892-A1 | COAGULATION FACTOR IX CONJUGATES | Novo Nordisk Health Care AG (CH) | 2016-12-21 | — | — | EP | disclosed |
| EP-1140895-B1 | THIOPYRAN COMPOUNDS AS INHIBITORS OF MMP | FUJISAWA PHARMACEUTICAL CO (JP) | 2004-03-24 | — | — | EP | disclosed |
| WO-2003068807-A2 | ECHINOCANDIN CYCLIC PEPTIDE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-08-21 | — | — | WO | disclosed |
| US-6608192-B1 | Pyrrolobenzodiazepines | SPIROGEN LIMITED (GB) | 2003-08-19 | — | — | US | disclosed |
| WO-2002093131-A2 | METHODS FOR ISOLATING AND LABELING SAMPLE MOLECULES | THE INSTITUTE FOR SYSTEMS BIOLOGY (US) | 2002-11-21 | — | — | WO | disclosed |
| EP-1140895-A2 | THIOPYRAN COMPOUNDS AS INHIBITORS OF MMP | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-10-10 | — | — | EP | disclosed |
| EP-1107969-A2 | COLLECTIONS OF COMPOUNDS | Spirogen Limited (GB) | 2001-06-20 | — | — | EP | disclosed |
| WO-2000040576-A2 | THIOPYRAN COMPOUNDS AS INHIBITORS OF MMP | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-07-13 | — | — | WO | disclosed |
| WO-2000012506-A2 | COLLECTIONS OF COMPOUNDS | SPIROGEN LIMITED (GB) | 2000-03-09 | — | — | WO | disclosed |